- Home
- EE vs AQST Comparison
EE vs AQST Comparison
Compare EE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EE
- AQST
- Stock Information
- Founded
- EE 2003
- AQST 2004
- Country
- EE United States
- AQST United States
- Employees
- EE N/A
- AQST N/A
- Industry
- EE Oil/Gas Transmission
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- EE Utilities
- AQST Health Care
- Exchange
- EE Nasdaq
- AQST Nasdaq
- Market Cap
- EE 902.1M
- AQST 809.3M
- IPO Year
- EE 2022
- AQST 2018
- Fundamental
- Price
- EE $26.62
- AQST $6.01
- Analyst Decision
- EE Buy
- AQST Strong Buy
- Analyst Count
- EE 7
- AQST 7
- Target Price
- EE $33.00
- AQST $10.00
- AVG Volume (30 Days)
- EE 452.3K
- AQST 3.0M
- Earning Date
- EE 11-05-2025
- AQST 11-05-2025
- Dividend Yield
- EE 1.20%
- AQST N/A
- EPS Growth
- EE 51.11
- AQST N/A
- EPS
- EE 1.42
- AQST N/A
- Revenue
- EE $1,185,262,000.00
- AQST $43,397,000.00
- Revenue This Year
- EE $27.08
- AQST N/A
- Revenue Next Year
- EE $29.30
- AQST $51.39
- P/E Ratio
- EE $18.75
- AQST N/A
- Revenue Growth
- EE 45.09
- AQST N/A
- 52 Week Low
- EE $21.29
- AQST $2.12
- 52 Week High
- EE $32.99
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- EE 48.68
- AQST 52.24
- Support Level
- EE $25.78
- AQST $5.53
- Resistance Level
- EE $27.18
- AQST $6.17
- Average True Range (ATR)
- EE 1.11
- AQST 0.43
- MACD
- EE -0.08
- AQST 0.00
- Stochastic Oscillator
- EE 16.56
- AQST 53.66
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.